há 1 dia
Hypertension: ARB plus CCB shows the best tolerability for short-term BP therapy
Network meta-analysis of 716 double-blind RCTs with 159,362 participants found fewer AE-driven discontinuations with ARB-containing regimens, while CCBs, ACE inhibitor plus CCB, and beta-blocker plus thiazide increased withdrawals vs placebo.